Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines.Trump health officials plan to include the claim in a presentation next week to a panel of advisors to the CDC that is considering new COVID vaccine recommendations, which can impact access to the shots and whether they’re free, according to the Washington Post.Those deaths were seemingly gathered from information submitted to the govern ...

Companies that manufacture authorized COVID-19 shots are down significantly following word that a closely watched CDC vaccines advisory committee meeting next week will receive a presentation tying the vaccines to the deaths of 25 children. Moderna (NASDAQ:MRNA), Pfizer ( ...

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report from the Washington Post said officials plan to include the claim in a presentation next week to a key vaccine panel that advises the Centers for Disease Control and Prevention. That committee play ...

We do have a news alert today on COVID vaccines and for that we'll turn back to Angelica Peebles. Hi Angelica. Hey Carl.Well the Washington Post is reporting that Trump health officials plan to link coronavirus vaccines to the deaths of 25 children and that is that comes as next week this um the CDC advisers on vaccines will weigh how those co vaccines should be used going forward. This has obviously been a very contentious issue and the Washington Post is citing people familiar with this. We of course have ...

格隆汇9月12日｜Moderna(MRNA.US)、辉瑞(PFE.US)、BioNTech SE(BNTX.US)短线下挫，跌至盘中低 点。消息面上，华盛顿邮报称，美国总统特朗普政府官员将把25名儿童死亡事件与新冠疫苗联系起来。 ...

（文章来源：每日经济新闻） 每经AI快讯，9月12日，Moderna、辉瑞、BioNTech SE短线下挫，跌至盘中低点。 ...

As HHS Secretary Robert F. Kennedy Jr. continues to fend off criticism of his leadership and decisions at the agency, if he were to leave the post, Gilead Sciences (NASDAQ:GILD), Moderna (NASDAQ:MRNA), and Biohaven (NYSE: ...

PresentationTerence FlynnEquity Analyst All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's large-cap U.S. biopharma analyst. I'm very pleased to be hosting Moderna. We have Stéphane Bancel, who's the company's CEO. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Stephane, thank you so much for joining ...

Moderna (NasdaqGS:MRNA) FY Conference September 08, 2025 10:00 AM ET Company ParticipantsStéphane Bancel - CEO & DirectorConference Call ParticipantsTerence Flynn - Equity Research AnalystTerence FlynnAll right. Great. Thanks for joining us, everybody. I'm Terrence Flynn, Morgan Stanley's large-cap US biopharma analyst. I'm very pleased to be hosting Moderna. We have Stéphane Bancel, who's the company's CEO. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganst ...

监管政策调整 - FDA撤销新冠疫苗紧急使用授权 该授权曾被用于支持全民接种强制令 [1] - 对辉瑞疫苗接种对象实施更严格限制 仅限5岁及以上人群使用 [1] - Moderna疫苗仍可供6个月及以上儿童接种 Novavax疫苗限12岁及以上人群使用 [1] - 相比拜登政府时期推荐所有6个月以上美国人每年接种一次的政策 此次调整明显收紧 [1] 产品批准更新 - FDA批准辉瑞Comirnaty品牌的补充生物制品许可申请 [1] - 批准范围针对65岁及以上人群 以及5至64岁患有基础疾病且存在新冠重症风险的群体 [1] 市场反应 - Moderna股价上涨1.5% 辉瑞微涨0.6% 诺瓦瓦克斯上涨1.07% [2] - 以辉瑞为主要成份股的医疗保健精选板块ETF小幅上涨 [2] 待决事项 - 无基础疾病的健康人群疫苗可及性尚未明确 [1] - 保险公司是否继续为相关人群承担费用存在不确定性 [1]